Based on recent data, Horizon Therapeutics Public Limited Company (HZNP) shows an Average True Range (ATR) of N/A and an Enterprise Value of N/A. Its average trading volume over the past 3 months is N/A, indicating liquidity. These fundamental metrics provide insight into HZNP's underlying financial health and market activity.
| ATR | N/A |
| Enterprise Value | - |
| Avg Vol (3 Months) | - |
| Avg Vol (10 Days) | - |
Horizon Therapeutics Public Limited Company (HZNP) technical indicators as of February 6, 2026: the SMA 20 is N/A, SMA 50 at N/A, and SMA 200 at N/A. The RSI 14 value is N/A, suggesting its current momentum. These technical analysis signals help assess HZNP's price trends and potential future movements.
| SMA 20 | N/A |
| SMA 50 | N/A |
| SMA 200 | N/A |
| RSI 14 | N/A |
Horizon Therapeutics Public Limited Company (HZNP) stock performance overview as of February 6, 2026: The 52-week high is N/A (currently N/A below), and the 52-week low is N/A (currently N/A above). Over the past year, HZNP's performance is 78.7%, compared to the S&P 500's 8.96% change.
| 52-Week High | N/A |
| 52-Week High Chg | - |
| 52-Week Low | N/A |
| 52-Week Low Chg | - |
| S&P 500 52-Week Chg | 8.96% |
According to market data, Horizon Therapeutics Public Limited Company (HZNP) stock's recent performance metrics show that over the last month, HZNP is 15.18%, with a Year-to-Date (YTD) performance of 53.18%. Over the past year, the stock has seen a 78.7% change. These figures summarize HZNP's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | N/A | N/A | N/A | N/A | N/A | N/A |
| Low | N/A | N/A | N/A | N/A | N/A | N/A |
| Performance | -3.95% | +15.18% | +73.82% | +72.08% | +78.70% | +53.18% |
According to current financial data, HZNP stock's P/E (TTM) ratio is 51.10, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for HZNP, including P/S (7.33), P/B (5.25), and P/FCF (23.51), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | HZNP | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | 51.1 | -1.23 | 69.86 | 32.59 |
| P/S (TTM) | 7.33 | 3.71 | 4.68 | 5.98 |
| P/B (TTM) | 5.25 | 0.23 | -0.45 | 5.45 |
| P/FCF (TTM) | 23.51 | -7.07 | 17.79 | 31.94 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep